Developing Vaccine Educators Within Practices of Community Healthcare Providers: a Pragmatic, Randomized Controlled Trial of Peer Education to Promote Vaccine Acceptance

NYU Langone Health1 个研究点分布在 1 个国家目标入组 154 人2022年3月6日

适应症Vaccine Acceptance

概览

阶段: 不适用
干预措施: 未指定
疾病 / 适应症: Vaccine Acceptance
发起方: NYU Langone Health
入组人数: 154
试验地点: 1
主要终点: Number of Participants Ages 0 Months to 18 Months at Enrollment who Receive at least One Dose of PCV-13 Vaccine by 3 Months Post-Enrollment
状态: 已完成
最后更新: 2年前

概览研究者入排标准结局指标研究点相似试验

概览

简要总结

Effective interventions to improve uptake of vaccines among hesitant groups are urgently needed. Peer education is an effective intervention in modifying health behaviors in other conditions and may be effective in promoting vaccine confidence but has not been studied. To fill this knowledge gap, we will enroll approximately 152 parents of children age 0-18 months who are eligible for pneumococcal conjugate (PCV-13) vaccine and randomize them 1:1 to a peer-led vaccine education intervention or usual care.

注册库

clinicaltrials.gov

开始日期

2022年3月6日

结束日期

2023年8月1日

最后更新

2年前

研究类型

Interventional

研究设计

Parallel

性别

All

研究者

发起方

NYU Langone Health

责任方

Sponsor

入排标准

入选标准

•A parent of a child aged 0 to 18 months born at ≥35 weeks' gestation who is eligible for a dose of PCV-
•Eligibility by age defined as follows:
•Age 0-6 months: never received first dose or is \>8 weeks from last dose (3 doses scheduled in this age group at 2, 4, and 6 months)
•Age 7-11 months: never received first dose or is \> 8 weeks from last dose (2 doses scheduled in this age group if started at 7 months)
•12-18 months: never received first dose, is \>8 weeks from last dose (2 doses scheduled in this age group if started at 12 months) or is due for booster at 12-18 months having received primary series between age 2-11 months.
•Self-identifies as Orthodox Jewish.
•Is able to provide informed consent.

排除标准

•Unable to communicate verbally in English or Yiddish
•Unwilling or unable to utilize a Yiddish in-person or telephone interpreter
•Has already participated in this study as an eligible adult or parent. A parent will only be able to participate in this study once (i.e. for only one child in the family that is eligible)
•Has an appointment at clinic that day to specifically receive vaccines.

结局指标

主要结局

Number of Participants Ages 0 Months to 18 Months at Enrollment who Receive at least One Dose of PCV-13 Vaccine by 3 Months Post-Enrollment

时间窗: Month 3 Post-Enrollment

Outcome will be determined via review of patient medical chart.

次要结局

Number of Participants Ages 1 Month to 18 Months at Enrollment who Receive at least One Dose of PCV-13 Vaccine by 1 Month Post-Enrollment(Month 1 Post-Enrollment)
Percentage of Days Under-immunized at 3 Months among Participants Ages 0 Months to 18 Months at Enrollment(Month 1 Post-Enrollment)